Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
LPI (LP Information)' newest research report, the “Transplantation of Multipotent Hematopoietic Stem Cells Industry Forecast” looks at past sales and reviews total world Transplantation of Multipotent Hematopoietic Stem Cells sales in 2022, providing a comprehensive analysis by region and market sector of projected Transplantation of Multipotent Hematopoietic Stem Cells sales for 2023 through 2029. With Transplantation of Multipotent Hematopoietic Stem Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transplantation of Multipotent Hematopoietic Stem Cells industry.
This Insight Report provides a comprehensive analysis of the global Transplantation of Multipotent Hematopoietic Stem Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transplantation of Multipotent Hematopoietic Stem Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transplantation of Multipotent Hematopoietic Stem Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transplantation of Multipotent Hematopoietic Stem Cells and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transplantation of Multipotent Hematopoietic Stem Cells.
The global Transplantation of Multipotent Hematopoietic Stem Cells market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Transplantation of Multipotent Hematopoietic Stem Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Transplantation of Multipotent Hematopoietic Stem Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Transplantation of Multipotent Hematopoietic Stem Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Transplantation of Multipotent Hematopoietic Stem Cells players cover CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group and CellGenix Technologie Transfer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Transplantation of Multipotent Hematopoietic Stem Cells market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cells Storage
Stem Cells Consumables
Segmentation by application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size 2018-2029 2.1.2 Transplantation of Multipotent Hematopoietic Stem Cells Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Transplantation of Multipotent Hematopoietic Stem Cells Segment by Type 2.2.1 Stem Cells Storage 2.2.2 Stem Cells Consumables 2.3 Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type 2.3.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Market Share by Type (2018-2023) 2.4 Transplantation of Multipotent Hematopoietic Stem Cells Segment by Application 2.4.1 Leukemia 2.4.2 Lymphoproliferative Disorders 2.4.3 Solid Tumors 2.4.4 Non-Malignant Disorders 2.5 Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application 2.5.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Size Market Share by Application (2018-2023) 3 Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Player 3.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Size Market Share by Players 3.1.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue by Players (2018-2023) 3.1.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Revenue Market Share by Players (2018-2023) 3.2 Global Transplantation of Multipotent Hematopoietic Stem Cells Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Transplantation of Multipotent Hematopoietic Stem Cells by Regions 4.1 Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Regions (2018-2023) 4.2 Americas Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth (2018-2023) 4.3 APAC Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth (2018-2023) 4.4 Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth (2018-2023) 4.5 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size Growth (2018-2023) 5 Americas 5.1 Americas Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Country (2018-2023) 5.2 Americas Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type (2018-2023) 5.3 Americas Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Region (2018-2023) 6.2 APAC Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type (2018-2023) 6.3 APAC Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Transplantation of Multipotent Hematopoietic Stem Cells by Country (2018-2023) 7.2 Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type (2018-2023) 7.3 Europe Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells by Region (2018-2023) 8.2 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Type (2018-2023) 8.3 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Regions (2024-2029) 10.1.1 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Regions (2024-2029) 10.1.2 Americas Transplantation of Multipotent Hematopoietic Stem Cells Forecast 10.1.3 APAC Transplantation of Multipotent Hematopoietic Stem Cells Forecast 10.1.4 Europe Transplantation of Multipotent Hematopoietic Stem Cells Forecast 10.1.5 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Forecast 10.2 Americas Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Country (2024-2029) 10.2.1 United States Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.2.2 Canada Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.2.3 Mexico Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.2.4 Brazil Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3 APAC Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Region (2024-2029) 10.3.1 China Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3.2 Japan Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3.3 Korea Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3.4 Southeast Asia Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3.5 India Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.3.6 Australia Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.4 Europe Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Country (2024-2029) 10.4.1 Germany Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.4.2 France Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.4.3 UK Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.4.4 Italy Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.4.5 Russia Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.5 Middle East & Africa Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Region (2024-2029) 10.5.1 Egypt Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.5.2 South Africa Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.5.3 Israel Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.5.4 Turkey Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.5.5 GCC Countries Transplantation of Multipotent Hematopoietic Stem Cells Market Forecast 10.6 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Type (2024-2029) 10.7 Global Transplantation of Multipotent Hematopoietic Stem Cells Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 CBR Systems 11.1.1 CBR Systems Company Information 11.1.2 CBR Systems Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.1.3 CBR Systems Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 CBR Systems Main Business Overview 11.1.5 CBR Systems Latest Developments 11.2 China Cord Blood Corporation 11.2.1 China Cord Blood Corporation Company Information 11.2.2 China Cord Blood Corporation Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.2.3 China Cord Blood Corporation Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 China Cord Blood Corporation Main Business Overview 11.2.5 China Cord Blood Corporation Latest Developments 11.3 ViaCord 11.3.1 ViaCord Company Information 11.3.2 ViaCord Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.3.3 ViaCord Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 ViaCord Main Business Overview 11.3.5 ViaCord Latest Developments 11.4 Thermo Fisher Scientific 11.4.1 Thermo Fisher Scientific Company Information 11.4.2 Thermo Fisher Scientific Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.4.3 Thermo Fisher Scientific Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Thermo Fisher Scientific Main Business Overview 11.4.5 Thermo Fisher Scientific Latest Developments 11.5 STEMCELL Technologies 11.5.1 STEMCELL Technologies Company Information 11.5.2 STEMCELL Technologies Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.5.3 STEMCELL Technologies Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 STEMCELL Technologies Main Business Overview 11.5.5 STEMCELL Technologies Latest Developments 11.6 Vcanbio 11.6.1 Vcanbio Company Information 11.6.2 Vcanbio Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.6.3 Vcanbio Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Vcanbio Main Business Overview 11.6.5 Vcanbio Latest Developments 11.7 Merck Millipore 11.7.1 Merck Millipore Company Information 11.7.2 Merck Millipore Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.7.3 Merck Millipore Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Merck Millipore Main Business Overview 11.7.5 Merck Millipore Latest Developments 11.8 Lonza Group 11.8.1 Lonza Group Company Information 11.8.2 Lonza Group Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.8.3 Lonza Group Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Lonza Group Main Business Overview 11.8.5 Lonza Group Latest Developments 11.9 CellGenix Technologie Transfer 11.9.1 CellGenix Technologie Transfer Company Information 11.9.2 CellGenix Technologie Transfer Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.9.3 CellGenix Technologie Transfer Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 CellGenix Technologie Transfer Main Business Overview 11.9.5 CellGenix Technologie Transfer Latest Developments 11.10 ThermoGenesis 11.10.1 ThermoGenesis Company Information 11.10.2 ThermoGenesis Transplantation of Multipotent Hematopoietic Stem Cells Product Offered 11.10.3 ThermoGenesis Transplantation of Multipotent Hematopoietic Stem Cells Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 ThermoGenesis Main Business Overview 11.10.5 ThermoGenesis Latest Developments 12 Research Findings and Conclusion